Sales decline 0.98% to Rs 11.12 crore
Net profit of Sandu Pharmaceuticals rose 11.11% to Rs 0.20 crore in the quarter ended March 2017 as against Rs 0.18 crore during the previous quarter ended March 2016. Sales declined 0.98% to Rs 11.12 crore in the quarter ended March 2017 as against Rs 11.23 crore during the previous quarter ended March 2016.For the full year,net profit declined 22.22% to Rs 0.42 crore in the year ended March 2017 as against Rs 0.54 crore during the previous year ended March 2016. Sales rose 9.10% to Rs 44.82 crore in the year ended March 2017 as against Rs 41.08 crore during the previous year ended March 2016.
ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales11.1211.23 -1 44.8241.08 9 OPM %6.127.66 -5.917.04 - PBDT0.380.52 -27 1.551.40 11 PBT0.200.19 5 0.830.71 17 NP0.200.18 11 0.420.54 -22
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
